Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B.

[1]  S. Davis,et al.  Toxicity of amphotericin B emulsion formulations. , 1993, The Journal of antimicrobial chemotherapy.

[2]  N. Charlier,et al.  Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. , 1992, BMJ.

[3]  P. Moreau,et al.  Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients. , 1992, The Journal of antimicrobial chemotherapy.

[4]  R. Coker.  Cryptococcal Infection in AIDS , 1992, International journal of STD & AIDS.

[5]  H. Gadner,et al.  Conventional vs. liposomal amphotericin B in immunosuppressed children. , 1992, Pediatric hematology and oncology.

[6]  M. Saag,et al.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. , 1992, The New England journal of medicine.

[7]  R. Coker,et al.  Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS. , 1991, The Journal of antimicrobial chemotherapy.

[8]  R. M. Tucker,et al.  Itraconazole therapy for cryptococcal meningitis and cryptococcosis. , 1989, Archives of internal medicine.

[9]  W. Dismukes.  Cryptococcal meningitis in patients with AIDS. , 1988, The Journal of infectious diseases.

[10]  A. Zuger,et al.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. , 1986, Annals of internal medicine.

[11]  D. Warnock,et al.  Clinical Pharmacokinetics of Systemic Antifungal Drugs , 1983, Clinical pharmacokinetics.

[12]  J. Richardson,et al.  Therapy with amphotericin B of Candida septicemia in the presence of acute renal failure. , 1968, Investigative urology.